Human plasma pooled and treated for

HUMAN PLASMA FOR FRACTIONATION - …

EUROPEAN PHARMACOPOEIA 6.0 Human plasma (pooled and treated for virus inactivation) LABELLING.).). ().). (

  Human, Pooled, Plasma, Treated, Human plasma for fractionation, Fractionation, Human plasma, Pooled and treated for

T I S S E E L [Fibrin Sealant] - Baxter Healthcare

The major component of the clottable protein (human origin) is fibrinogen. The fibrinogen molecule is a dimer composed of two symmetrical subunits linked by S--S - bonds.

  Human, Sealant, E e l, Fibrin sealant, Fibrin

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

1 NAME OF THE MEDICINAL PRODUCT TachoSil sealant matrix. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION TachoSil contains per cm2: Human Fibrinogen 5.5 mg

  Product, Human

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

7 Table 1: Pharmacokinetic interactions between brivaracetam and other AEDs AED coadministered Influence of AED on brivaracetam plasma concentration

  Plasma

FLOSEAL Hemostatic Matrix, 5 mL

FLOSEAL Hemostatic Matrix, 5 mL Instructions for Use Caution: Federal Law (United States) restricts this device to sale by or on the order of a licensed healthcare practitioner.

  Matrix, Floseal hemostatic matrix, Floseal, Hemostatic, 5 ml

FloSeal Hemostatic Matrix - Baxter Healthcare

FloSeal Hemostatic Matrix Instructions for Use Caution: Federal Law restricts this device to sale by or on the order of a physician (or properly licensed practi-

  Matrix, Floseal hemostatic matrix, Floseal, Hemostatic

en - Ilex Medical Ltd.

system 1 en HCV Ag 6L47 F5-Y206-2/R1 HCV Ag Customer Service International: Call your Abbott representative This package insert must be read carefully prior to use.